2023-2029 Global Stem Cell Exosome Therapeutic Industry Research & Trends Analysis Report
Report Code: KNJ1665320 No. of Pages: 156 Category: Services
Publisher: Date of Publish:
Publisher: Date of Publish:
According to YH Research, the global market for Stem Cell Exosome Therapeutic should grow from US$ 153 million in 2022 to US$ 410.5 million by 2029, with a CAGR of 15.6% for the period of 2023-2029.
China Stem Cell Exosome Therapeutic market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Stem Cell Exosome Therapeutic market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Mesenchymal Stem Cell (MSC) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Precision Medicine has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Stem Cell Exosome Therapeutic include Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech, ExoCoBio, Exopharm, OmniSpiant, BrainStorm Cell Therapeutics and Novadip Biosciences, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Exosome therapy involves using exosomes, small vesicles that are naturally produced by stem cells, to deliver therapeutic molecules to specific cells in the body.
This report aims to provide a comprehensive study of the global market for Stem Cell Exosome Therapeutic. Report Highlights:
(1) Global Stem Cell Exosome Therapeutic market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Stem Cell Exosome Therapeutic market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Stem Cell Exosome Therapeutic market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Stem Cell Exosome Therapeutic segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Stem Cell Exosome Therapeutic segment by type and by application and regional segment by type and by application.
(6) Stem Cell Exosome Therapeutic industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Mesenchymal Stem Cell (MSC)
Dendritic Cells
Umbilical MSC
Others
Market segment by application, can be divided into
Precision Medicine
Regenerative Medicine
Others
Market segment by players, this report covers
Aegle Therapeutics
Brexogen
Cell Care Therapeutics
CHA Biotech
ExoCoBio
Exopharm
OmniSpiant
BrainStorm Cell Therapeutics
Novadip Biosciences
Unicyte AG
Exogenus Therapeutics
Creative Medical Tech
Anjarium Biosciences
Capricor Therapeutics
Kimera Labs ReNeuron
Stem Cell Medicine
Codiak Biosciencesare
1 Market Overview
1.1 Product Overview and Scope of Stem Cell Exosome Therapeutic
1.2 Global Stem Cell Exosome Therapeutic Market Size and Forecast
1.3 China Stem Cell Exosome Therapeutic Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Stem Cell Exosome Therapeutic Share in Global Market, 2018-2029
1.4.2 Stem Cell Exosome Therapeutic Market Size: China VS Global, 2018-2029
1.5 Stem Cell Exosome Therapeutic Market Dynamics
1.5.1 Stem Cell Exosome Therapeutic Market Drivers
1.5.2 Stem Cell Exosome Therapeutic Market Restraints
1.5.3 Stem Cell Exosome Therapeutic Industry Trends
1.5.4 Stem Cell Exosome Therapeutic Industry Policy
2 Global Competitive Situation by Company
2.1 Global Stem Cell Exosome Therapeutic Revenue by Company (2018-2023)
2.2 Global Stem Cell Exosome Therapeutic Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Stem Cell Exosome Therapeutic Concentration Ratio
2.4 Global Stem Cell Exosome Therapeutic Mergers & Acquisitions, Expansion Plans
2.5 Global Stem Cell Exosome Therapeutic Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Stem Cell Exosome Therapeutic Revenue by Company (2018-2023)
3.2 China Stem Cell Exosome Therapeutic Stem Cell Exosome Therapeutic Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Stem Cell Exosome Therapeutic, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Stem Cell Exosome Therapeutic Industry Chain
4.2 Stem Cell Exosome Therapeutic Upstream Analysis
4.3 Stem Cell Exosome Therapeutic Midstream Analysis
4.4 Stem Cell Exosome Therapeutic Downstream Analysis
5 Sights by Type
5.1 Stem Cell Exosome Therapeutic Classification
5.1.1 Mesenchymal Stem Cell (MSC)
5.1.2 Dendritic Cells
5.1.3 Umbilical MSC
5.1.4 Others
5.2 By Type, Global Stem Cell Exosome Therapeutic Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Stem Cell Exosome Therapeutic Revenue, 2018-2029
6 Sights by Application
6.1 Stem Cell Exosome Therapeutic Segment by Application
6.1.1 Precision Medicine
6.1.2 Regenerative Medicine
6.1.3 Others
6.2 By Application, Global Stem Cell Exosome Therapeutic Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Stem Cell Exosome Therapeutic Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Stem Cell Exosome Therapeutic Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Stem Cell Exosome Therapeutic Market Size, 2018-2029
7.3 North America
7.3.1 North America Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Stem Cell Exosome Therapeutic Market Size Market Share
7.4 Europe
7.4.1 Europe Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Stem Cell Exosome Therapeutic Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Stem Cell Exosome Therapeutic Market Size Market Share
7.6 South America
7.6.1 South America Stem Cell Exosome Therapeutic Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Stem Cell Exosome Therapeutic Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Stem Cell Exosome Therapeutic Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.3.2 By Company, U.S. Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.4.2 By Company, Europe Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.5.2 By Company, China Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.5.3 By Type, China Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.6.2 By Company, Japan Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.7.2 By Company, South Korea Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.9.2 By Company, India Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.9.3 By Type, India Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Stem Cell Exosome Therapeutic Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Stem Cell Exosome Therapeutic Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Aegle Therapeutics
9.1.1 Aegle Therapeutics Company Information, Head Office, Market Area and Industry Position
9.1.2 Aegle Therapeutics Company Profile and Main Business
9.1.3 Aegle Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.1.4 Aegle Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.1.5 Aegle Therapeutics Recent Developments
9.2 Brexogen
9.2.1 Brexogen Company Information, Head Office, Market Area and Industry Position
9.2.2 Brexogen Company Profile and Main Business
9.2.3 Brexogen Stem Cell Exosome Therapeutic Models, Specifications and Application
9.2.4 Brexogen Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.2.5 Brexogen Recent Developments
9.3 Cell Care Therapeutics
9.3.1 Cell Care Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Cell Care Therapeutics Company Profile and Main Business
9.3.3 Cell Care Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.3.4 Cell Care Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.3.5 Cell Care Therapeutics Recent Developments
9.4 CHA Biotech
9.4.1 CHA Biotech Company Information, Head Office, Market Area and Industry Position
9.4.2 CHA Biotech Company Profile and Main Business
9.4.3 CHA Biotech Stem Cell Exosome Therapeutic Models, Specifications and Application
9.4.4 CHA Biotech Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.4.5 CHA Biotech Recent Developments
9.5 ExoCoBio
9.5.1 ExoCoBio Company Information, Head Office, Market Area and Industry Position
9.5.2 ExoCoBio Company Profile and Main Business
9.5.3 ExoCoBio Stem Cell Exosome Therapeutic Models, Specifications and Application
9.5.4 ExoCoBio Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.5.5 ExoCoBio Recent Developments
9.6 Exopharm
9.6.1 Exopharm Company Information, Head Office, Market Area and Industry Position
9.6.2 Exopharm Company Profile and Main Business
9.6.3 Exopharm Stem Cell Exosome Therapeutic Models, Specifications and Application
9.6.4 Exopharm Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.6.5 Exopharm Recent Developments
9.7 OmniSpiant
9.7.1 OmniSpiant Company Information, Head Office, Market Area and Industry Position
9.7.2 OmniSpiant Company Profile and Main Business
9.7.3 OmniSpiant Stem Cell Exosome Therapeutic Models, Specifications and Application
9.7.4 OmniSpiant Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.7.5 OmniSpiant Recent Developments
9.8 BrainStorm Cell Therapeutics
9.8.1 BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position
9.8.2 BrainStorm Cell Therapeutics Company Profile and Main Business
9.8.3 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.8.4 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.8.5 BrainStorm Cell Therapeutics Recent Developments
9.9 Novadip Biosciences
9.9.1 Novadip Biosciences Company Information, Head Office, Market Area and Industry Position
9.9.2 Novadip Biosciences Company Profile and Main Business
9.9.3 Novadip Biosciences Stem Cell Exosome Therapeutic Models, Specifications and Application
9.9.4 Novadip Biosciences Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.9.5 Novadip Biosciences Recent Developments
9.10 Unicyte AG
9.10.1 Unicyte AG Company Information, Head Office, Market Area and Industry Position
9.10.2 Unicyte AG Company Profile and Main Business
9.10.3 Unicyte AG Stem Cell Exosome Therapeutic Models, Specifications and Application
9.10.4 Unicyte AG Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.10.5 Unicyte AG Recent Developments
9.11 Exogenus Therapeutics
9.11.1 Exogenus Therapeutics Company Information, Head Office, Market Area and Industry Position
9.11.2 Exogenus Therapeutics Company Profile and Main Business
9.11.3 Exogenus Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.11.4 Exogenus Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.11.5 Exogenus Therapeutics Recent Developments
9.12 Creative Medical Tech
9.12.1 Creative Medical Tech Company Information, Head Office, Market Area and Industry Position
9.12.2 Creative Medical Tech Company Profile and Main Business
9.12.3 Creative Medical Tech Stem Cell Exosome Therapeutic Models, Specifications and Application
9.12.4 Creative Medical Tech Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.12.5 Creative Medical Tech Recent Developments
9.13 Anjarium Biosciences
9.13.1 Anjarium Biosciences Company Information, Head Office, Market Area and Industry Position
9.13.2 Anjarium Biosciences Company Profile and Main Business
9.13.3 Anjarium Biosciences Stem Cell Exosome Therapeutic Models, Specifications and Application
9.13.4 Anjarium Biosciences Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.13.5 Anjarium Biosciences Recent Developments
9.14 Capricor Therapeutics
9.14.1 Capricor Therapeutics Company Information, Head Office, Market Area and Industry Position
9.14.2 Capricor Therapeutics Company Profile and Main Business
9.14.3 Capricor Therapeutics Stem Cell Exosome Therapeutic Models, Specifications and Application
9.14.4 Capricor Therapeutics Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.14.5 Capricor Therapeutics Recent Developments
9.15 Kimera Labs ReNeuron
9.15.1 Kimera Labs ReNeuron Company Information, Head Office, Market Area and Industry Position
9.15.2 Kimera Labs ReNeuron Company Profile and Main Business
9.15.3 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Models, Specifications and Application
9.15.4 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.15.5 Kimera Labs ReNeuron Recent Developments
9.16 Stem Cell Medicine
9.16.1 Stem Cell Medicine Company Information, Head Office, Market Area and Industry Position
9.16.2 Stem Cell Medicine Company Profile and Main Business
9.16.3 Stem Cell Medicine Stem Cell Exosome Therapeutic Models, Specifications and Application
9.16.4 Stem Cell Medicine Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.16.5 Stem Cell Medicine Recent Developments
9.17 Codiak Biosciencesare
9.17.1 Codiak Biosciencesare Company Information, Head Office, Market Area and Industry Position
9.17.2 Codiak Biosciencesare Company Profile and Main Business
9.17.3 Codiak Biosciencesare Stem Cell Exosome Therapeutic Models, Specifications and Application
9.17.4 Codiak Biosciencesare Stem Cell Exosome Therapeutic Revenue and Gross Margin, 2018-2023
9.17.5 Codiak Biosciencesare Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com